Genetic blockade of the insulin-like growth factor 1 receptor for human malignancy

Novartis Foundation Symposium

Volumn 262, Issue , 2004, Pages 177-192

  Adachi, Yasushi ^a   Lee, Choon Taek ^b   Carbone, David P ^c  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b Seoul National University College of Medicine   (South Korea)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL; DRUG ANTAGONISM; GENE THERAPY; HUMAN; METHODOLOGY; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GENE THERAPY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEOPLASMS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 16544381674     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (35)

1. Adachi Y, Lee CT, Coffee K et al 2002 Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines. Gastroenterology 123:1191-1204
2. Ankrapp DP, Bevan DR 1993 Insulin-like growth factor-I and human lung fibroblast-derived insulin-like growth factor-I stimulate the proliferation of human lung carcinoma cells in vitro. Cancer Res 53:3399-3404
3. Baserga R 1994 Oncogenes and the strategy of growth factors. Cell 79:927-930
4. Baserga R 1995 The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55:249-252
5. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M 1995 Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 55:2007-2011
6. Burgaud JL, Resnicoff M, Baserga R 1995 Mutant IGF-1 receptors as dominant negatives for growth and transformation. Biochem Biophys Res Commun 214:475-481
7. Chan JM, Stampfer MJ, Giovannucci E et al 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-566
8. D'Ambrosio C, Ferber A, Resnicoff M, Baserga R 1996 A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res 56:4013-4020
9. Dunn SE, Ehrlich M, Sharp NJ et al 1998 A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res 58:3353-3361
10. Freier S, Weiss O, Eran M et al 1999 Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut 44:704-708
11. Hankinson SE, Willett WC, Colditz GA et al 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
12. Hannon GJ 2002 RNA interference. Nature 418:244-251
13. Lahm H, Amstad P, Wyniger J et al 1994 Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int J Cancer 58:452-459
14. Lee CT, Wu S, Gabrilovich D et al 1996 Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res 56:3038-3041
15. Lee CT, Park KH, Adachi Y et al 2003 Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer. Cancer Gene Ther 10:57-63
16. Levitt RJ, Pollak M 2002 Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells. Cancer Res 62:7372-7376
17. Li S, Resnicoff M, Baserga R 1996 Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J Biol Chem 271:12254-12260
18. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
19. Long L, Rubin R, Baserga R, Brodt P 1995 Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res 55:1006-1009
20. Ma J, Pollak MN, Giovannucci E et al 1999 Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625
21. Maloney EK, McLaughlin JL, Dagdigian NE et al 2003 An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res 63:5073-5083
22. Min Y, Adachi Y, Yamamoto H et al 2003 Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer. Cancer Res 63:6432-6441
23. Nakanishi Y, Mulshine JL, Kasprzyk PG et al 1988 Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 82:354-359
24. Prager D, Li HL, Asa S, Melmed S 1994 Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA 91:2181-2185
25. Remacle-Bonnet M, Garrouste F, el Atiq F, Roccabianca M, Marvaldi J, Pommier G 1992 des-(1-3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells. Int J Cancer 52:910-917
26. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R 1994 Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res 54:4848-4850
27. Sara VR, Hall K 1990 Insulin-like growth factors and their binding proteins. Physiol Rev 70:591-614
28. Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R 1993 Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 90:11217-11221
29. Simmons JG, Pucilowska JB, Lund PK 1999 Autocrine and paracrine actions of intestinal fibroblast-derived insulin-like growth factors. Am J Physiol 276:G817-827
30. Stiles AD, D'Ercole AJ 1990 The insulin-like growth factors and the lung. Am J Respir Cell Mol Biol 3:93-100
31. Tai YT, Podar K, Catley L et al 2003 Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3′-kinase/AKT signaling. Cancer Res 63:5850-5858
32. Tang DC, Johnston SA, Carbone DP 1994 Butyrate-inducible and tumor-restricted gene expression by adenovirus vectors. Cancer Gene Ther 1:15-20
33. Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR 2001 AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res 61:589-593
34. Ullrich A, Gray A, Tam AW et al 1986 Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512
35. Yu H, Rohan T 2000 Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92:1472-1489